KRChoksey's research report on Colgate Palmolive (India)
Colgate Palmolive reported revenue decline of 4.1% YoY (down 2.9% QoQ) to INR 10,406 mn as toothpaste/toothbrush volumes were affected due to COVID-19 led lockdown and disruptions. EBITDA margin expanded to 29.6% in Q1FY21 (27.6% in Q1FY20). EBITDA increased 2.7% YoY/ +17.2% QoQ. Net Profit grew 17.2% YoY (down 2.9% QoQ) to INR 1,982 mn due to lower taxation rate. Net Profit margin for the quarter expanded by 346 bps YoY to 19.0% (flat QoQ).
Outlook
We apply a PE multiple of 43.5x on FY22E EPS of INR 34.6 (earlier 43.5x on INR 34.1) and arrive at a revised target price of INR 1,507 per share, an upside potential of 5.1% from CMP. Accordingly, we reiterate an “ACCUMULATE” rating on the shares of Colgate Palmolive.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.